HKG Equity Snapshot

6938 Weekly Equity Report

Suzhou Ribo Life Science Co

Interactive chart JSON snapshot
Latest Close 51.00 HKD 12 Jun 2026
1W Return -4.1% latest completed week
4W Return -15.6% short-term follow-through
12W Return -10.6% quarterly tape
Trend Breadth 0.0% 0 of 23 weeks active
Volume Ratio 1.2x vs 13-week average
Company Brief

What the company does

Suzhou Ribo Life Science Co., Ltd. researches and develops novel therapeutics for the treatment of cardiovascular, metabolic, renal, and liver diseases in Chinese mainland and internationally. It develops RBD4059, which is phase 2 clinical trial for treating thrombotic diseases; RBD5044 that is in phase 2 clinical trial for treating hypertrigly ceridemia; RBD7022, which is in phase 2 clinical trial for the treatment of hypercho lesterolemia; RBD7007 and RBD2080 that are in Phase I clinical trial for the treatment of renal diseases; and RBD1119 for treating thrombotic diseases that is in Phase I clinical trial. The …

Snapshot

What the weekly tape is saying

6938 closed the latest completed week at 51.00 HKD. The 4-week return is -15.6% and the 12-week return is -10.6%. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Risk-first tape with a 26/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -
Volume 1.2x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 5 Blend of 4-week and 12-week follow-through.
Dynamics 50 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 50 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
-
Vs Trend Line
-
Fair Value
64.40 HKD
Vs Fair Value
-20.8%
52W High
95.80 HKD
52W Low
46.54 HKD
Drawdown
-46.8%
Range Position
9.1%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -4.1%
4W -15.6%
12W -10.6%
26W -
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
HK Healthcare
Sector Rank
181 of 257
Sector Percentile
29.7%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.00
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Undecided
Probability
48.47%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
1.1M
13W Average
949.4K
52W Average
2.1M
Vs 13W
1.2x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
6.1%
52W Volatility
6.3%
Upside Weeks
10
Downside Weeks
12
Downside Breadth
54.5%
Avg Gain / Loss
3.7% / -6.6%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
9.9B

Opportunity signals

  • No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Market Dynamics is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.

Watch next

  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 51.00 HKD -4.1% - 64.40 HKD 0.00 - 1.1M Off
5 Jun 2026 53.20 HKD -8.6% - 65.00 HKD 0.00 - 712.6K Off
29 May 2026 58.20 HKD 3.0% - 65.57 HKD 0.00 - 794.5K Off
22 May 2026 56.50 HKD -6.5% - 65.94 HKD 0.00 - 628.4K Off
15 May 2026 60.45 HKD -0.9% - 66.43 HKD 0.00 - 1.3M Off
8 May 2026 61.00 HKD 0.2% - 66.76 HKD 0.00 - 1.5M Off
1 May 2026 60.90 HKD -2.6% - 67.10 HKD 0.00 - 867.0K Off
24 Apr 2026 62.50 HKD -5.2% - 67.49 HKD 0.00 - 775.1K Off
17 Apr 2026 65.90 HKD -6.7% - 67.82 HKD 0.00 - 1.8M Off
10 Apr 2026 70.60 HKD 9.1% - 67.96 HKD 0.00 - 807.9K Off
3 Apr 2026 64.70 HKD 13.1% - 67.76 HKD 0.00 - 697.2K Off
27 Mar 2026 57.20 HKD 0.3% - 68.01 HKD 0.00 - 1.0M Off
20 Mar 2026 57.05 HKD 2.0% - 69.00 HKD 0.00 - 345.2K Off
13 Mar 2026 55.95 HKD -7.1% - 70.19 HKD 0.00 - 1.4M Off